2-(4-chlorophenoxy)-1-(8,9-dimethylspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)ethanone
C25H26ClN3O2 — CID 53058180
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-chlorophenoxy)-1-(8,9-dimethylspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)ethanone
2-(4-chlorophenoxy)-1-(8,9-dimethylspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)ethanone (PubChem CID 53058180) has the molecular formula C25H26ClN3O2 and a molecular weight of 435.96 g/mol. Its IUPAC name is 2-(4-chlorophenoxy)-1-(8,9-dimethylspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)ethanone.
Molecular Properties
| Compound Name | 2-(4-chlorophenoxy)-1-(8,9-dimethylspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)ethanone |
|---|---|
| PubChem CID | 53058180 |
| Molecular Formula | C25H26ClN3O2 |
| Molecular Weight | 435.96 g/mol |
| Exact Mass | 435.17 |
| IUPAC Name | 2-(4-chlorophenoxy)-1-(8,9-dimethylspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)ethanone |
| SMILES | Cc1ccc2c(c1C)-n1cccc1C1(CCN(C(=O)COc3ccc(Cl)cc3)CC1)N2 |
| InChI | InChI=1S/C25H26ClN3O2/c1-17-5-10-21-24(18(17)2)29-13-3-4-22(29)25(27-21)11-14-28(15-12-25)23(30)16-31-20-8-6-19(26)7-9-20/h3-10,13,27H,11-12,14-16H2,1-2H3 |
| InChIKey | BOHSWHVFMPFNBL-UHFFFAOYSA-N |
| XLogP | 5.07 |
| TPSA | 46.50 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.96 |
| LogP ≤ 5 | 5.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53058180 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.